miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A. (Q39046050)

8 September 2017

title

miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A. (English)

1 reference

8 September 2017

1 reference

Haifeng Yang

1

1 reference

8 September 2017

Qi Li

2

1 reference

8 September 2017

Wohua Zhao

3

1 reference

8 September 2017

Dun Yuan

4

1 reference

8 September 2017

Hongyang Zhao

5

1 reference

8 September 2017

Yong Zhou

6

1 reference

8 September 2017

language of work or name

English

0 references

publication date

6 December 2013

1 reference

8 September 2017

1 reference

8 September 2017

volume

588

1 reference

8 September 2017

issue

1

1 reference

8 September 2017

page(s)

192-197

1 reference

Recent advances in neuroblastoma

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Identification of miRNAs that are associated with tumor metastasis in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Accurate prediction of neuroblastoma outcome based on miRNA expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

MicroRNA 329 suppresses angiogenesis by targeting CD146

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Integrated analysis of mRNA and microRNA expression in mature neurons, neural progenitor cells and neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Identification of microRNAs that regulate TLR2-mediated trophoblast apoptosis and inhibition of IL-6 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Lysine-specific demethylase 1 (LSD1/KDM1A) contributes to colorectal tumorigenesis via activation of the Wnt/β-catenin pathway by down-regulating Dickkopf-1 (DKK1) [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

High expression of lysine-specific demethylase 1 correlates with poor prognosis of patients with esophageal squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

The lysine specific demethylase-1 (LSD1/KDM1A) regulates VEGF-A expression in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

Loss of LSD1 (lysine-specific demethylase 1) suppresses growth and alters gene expression of human colon cancer cells in a p53- and DNMT1(DNA methyltransferase 1)-independent manner.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2013.11.036

10.1016/J.FEBSLET.2013.11.036

21 January 2018

Identifiers

DOI

1 reference

8 September 2017

1 reference